Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Xinqun Chen"'
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e106326 (2014)
The anterolateral thigh flap has been the workhouse flap for coverage of soft-tissue defects in head and neck for decades. However, the reconstruction of multiple and complex soft-tissue defects in head and neck with multipaddled anterolateral thigh
Externí odkaz:
https://doaj.org/article/4e82b730df9c4c6eae5789a6f81036af
Autor:
Chengsi Li, Tianyu Wang, Dongwei Wu, Haichuan Guo, Zhenbang Yang, Xinqun Cheng, Yanbin Zhu, Yingze Zhang, Jinjiao Li
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 16, Pp 1988-1990 (2024)
Externí odkaz:
https://doaj.org/article/3d6bdf6a80bd4afda8391046a16996a7
Publikováno v:
BMC Musculoskeletal Disorders, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Purpose This study aims to identify independent risk factors for preoperative lower extremity deep venous thrombosis (DVT) in patients with non-traumatic osteonecrosis of the femoral head (NONFH), and to develop a prediction nomogram. Method
Externí odkaz:
https://doaj.org/article/2904a156259c4b22a078dcc97cc09d22
Publikováno v:
Statistics in Medicine. 39:4133-4146
In randomized clinical trials with survival outcome, there has been an increasing interest in subgroup identification based on baseline genomic, proteomic markers or clinical characteristics. Some of the existing methods identify subgroups that benef
Publikováno v:
Journal of Orthopaedic Surgery and Research, Vol 19, Iss 1, Pp 1-9 (2024)
Abstract Background No large cohort study has evaluated the surgical outcomes of THA between different stages of ONFH patients. This study aimed to compare the surgical outcomes of ONFH patients who underwent THA in ARCO stage III versus IV, in terms
Externí odkaz:
https://doaj.org/article/bd892ca9772f4ee985d6e73b58f20960
Autor:
Jacob Sands, Martin Reck, Alejandro Navarro, Anne C. Chiang, Shun Lu, Nir Peled, Luis G. Paz-Ares, Samuel J. Kerr, Toshiaki Takahashi, Alexey Smolin, Xinqun Chen, Bin Zhao, Hazem Edmond El-Osta, Raffaele Califano
Publikováno v:
Journal of Clinical Oncology. 40:TPS8606-TPS8606
TPS8606 Background: Current standard of care immunotherapy plus chemotherapy options for first-line extensive-stage small-cell lung cancer (ES-SCLC) are associated with modest improvements in median OS and PFS. In the KEYNOTE-604 study, first-line pe
Autor:
Ning Li, Wen-Xuan Wang, J.J. Wu, Canhua Jiang, Xinqun Chen, Ya-Qin Hu, L.W. Ma, X. Gao, Jingfei Chen, An-jie Min
Publikováno v:
International journal of oral and maxillofacial surgery. 51(5)
The aim of this study was to evaluate the rare postoperative supraclavicular metastasis originating from oral squamous cell carcinoma (OSCC) and to discuss epidermal growth factor receptor (EGFR) as a potential predictive marker. Tumour specimens of
Autor:
Kohei Shitara, Mustafa Özgüroğlu, Yung-Jue Bang, Maria Di Bartolomeo, Mario Mandalà, Min-Hee Ryu, Lorenzo Fornaro, Tomasz Olesiński, Christian Caglevic, Hyun C Chung, Kei Muro, Eray Goekkurt, Wasat Mansoor, Raymond S McDermott, Einat Shacham-Shmueli, Xinqun Chen, Carlos Mayo, S Peter Kang, Atsushi Ohtsu, Charles S Fuchs, Guillermo Lerzo, Juan Manuel O'Connor, Guillermo Ariel Mendez, James Lynam, Niall Tebbutt, Mark Wong, Andrew Strickland, Chris Karapetis, David Goldstein, Paul Vasey, Jean-Luc Van Laethem, Eric Van Cutsem, Scott Berry, Mark Vincent, Bettina Muller, Felipe Rey, Angela Zambrano, Joaquin Guerra, Merete Krogh, Lene Baeksgaard, Mette Yilmaz, Anneli Elme, Andrus Magi, Paivi Auvinen, Tuomo Alanko, Markus Moehler, Volker Kunzmann, Thomas Seufferlein, Peter Thuss-Patience, Thomas Hoehler, Georg Haag, Salah-Eddin Al-Batran, Hugo Castro, Karla Lopez, Mynor Aguilar Vasquez, Mario Sandoval, Ka On Lam, Sinead Cuffe, Cathy Kelly, Ravit Geva, Ayala Hubert, Alex Beny, Baruch Brenner, Aprile Giuseppe, Alfredo Falcone, Evaristo Maiello, Rodolfo Passalacqua, Vincenzo Montesarchio, Hiroki Hara, Keisho Chin, Tomohiro Nishina, Yoshito Komatsu, Nozumo Machida, Shuichi Hironaka, Taroh Satoh, Takao Tamura, Naotaoshi Sugimoto, Haruhiko Cho, Yashushi Omuro, Ken Kato, Masahiro Goto, Ichinosuke Hyodo, Kazuhiro Yoshida, Hideo Baba, Taito Esaki, Junji Furuse, Wan Zamaniah Wan Mohammed, Carlos Hernandez Hernandez, Juan Casas Garcia, Adriana Dominguez Andrade, Katriona Clarke, Geir Hjortland, Nils Glenjen, Tomasz Kubiatowski, Jassem Jacek, Marek Wojtukiewicz, Sergey Lazarev, Yuri Lancukhay, Sergey Afanasayev, Vladimir Moiseyenko, Vladimir Kostorov, Svetlana Protsenko, Vadim Shirinkin, Dina Sakaeva, Natalia Fadeeva, Wei Peng Yong, Chau Hsien Matthew Ng, Barbara Robertson, Bernardo Rapaport, Graham Cohen, Lydia Dreosti, Paul Ruff, Conrad Jacobs, Gregory Landers, Waldemar Szpak, Sang-Young Roh, Jeeyun Lee, Yeul Hong Kim, Hyun Cheol Chung, Maria Alsina Maqueda, Federico Longo Munoz, Andres Cervantes Aguilar, Enrique Aranda Aguilar, Pilar Garcia Alfonso, Fernando Rivera, Jaime Feliu Batle, Roberto Pazo Cid, Kun-Huei Yeh, Jen-Shi Chen, Yee Chao, Chia-Jui Yen, Oguz Kara, Suayib Yalcin, Daniel Hochhauser, Ian Chau, Al Benson, Veena Shankaran, Walid Shaib, Philip Philip, Vivek Sharma, Robert Siegel, Weijing Sun, Zev Wainberg, Ben George, Andrea Bullock, Samuel Myrick, Josephine Faruol, Richard Siegel, Timothy Larson, Carlos Becerra, Suresh Ratnam, Donald A. Richards, Stephen L. Riche
Publikováno v:
The Lancet. 392:123-133
Summary Background Patients with advanced gastric or gastro-oesophageal junction cancer that progresses on chemotherapy have poor outcomes. We compared pembrolizumab with paclitaxel in patients with advanced gastric or gastro-oesophageal junction can
Autor:
Tianyu Wang, Congliang Gao, Dongwei Wu, Chengsi Li, Xinqun Cheng, Zhenbang Yang, Yingze Zhang, Yanbin Zhu
Publikováno v:
BMC Musculoskeletal Disorders, Vol 24, Iss 1, Pp 1-9 (2023)
Abstract Background The primary objectives of this study were to focus on one - year unplanned readmissions after THA in ONFH patients and to investigate rates, causes, and independent risk factors. Methods Between October 2014 and April 2019, eligib
Externí odkaz:
https://doaj.org/article/38ebc4676fe34069a9174561a3b745b8
Autor:
Yelena Yuriy Janjigian, Yung-Jue Bang, Charles S. Fuchs, Shukui Qin, Taroh Satoh, Kohei Shitara, Josep Tabernero, Eric Van Cutsem, Z. Alexander Cao, Xinqun Chen, S. Peter Kang, Chie-Schin Shih, Hyun Cheol Chung
Publikováno v:
Journal of Clinical Oncology. 37:TPS4146-TPS4146
TPS4146 Background: Combination therapy with the anti-HER2 antibody trastuzumab with fluoropyrimidine and platinum is the current standard for patients with HER2+ mG/GEJc. We hypothesize that combination anti–PD-1 and anti-HER2 therapy will result